Uncategorized
2024 Legal Opinions on the Compliance and Clinical Use of Regenative’s Wharton’s Jelly Products
Sep 26, 2024
“At Regenative, we are committed to providing the regulatory clarity and legal protection you need to focus on what matters… Read More >
Wharton’s Jelly Advancements: Post-Surgical Breast Reduction
Dec 12, 2022
Click Here to Read and Download the Case Study RESEARCH ARTICLE Case study presented by Dr. Allen Meglin uncovers new… Read More >
Advances through Value-Based Outcomes
Nov 30, 2022
This month marks five years since the FDA HCT/P regulations were first introduced. In that time we have (1) produced… Read More >
Research, Not Rebates
Nov 22, 2022
We know physicians drive innovation in medicine, and we are dedicated to our data-driven, outcomes-focused approach to advance this field… Read More >
Regenative Labs announces groundbreaking Wharton’s Jelly research demonstrating HCT/P compliance after processing
Aug 15, 2022
This includes the analogous nature of articular cartilage, muscle fascia, and intervertebral disc confirmed by way of comparative Scanning Electron… Read More >
Regenative Labs Releases New Study To Revolutionize Treatment For Patients With Diabetic Foot Ulcers
Aug 08, 2022
Future applications for the early, preventative use of amniotic membrane allografts in addition to the current standard of care for… Read More >
Regenative Labs And AAPC Announce Collaboration To Further Healthcare Compliance
Aug 01, 2022
PENSACOLA, Fla., Aug. 1, 2022 /PRNewswire/ — Regenative Labs, a leading HCT/P manufacturer, and AAPC, the nation’s largest medical coding, training, and… Read More >
Institutional Review Board Approves Regenative Labs’ Protocol For Key Data Collection
Jul 08, 2022
Regenative Labs CEO predicts this will have significant implications to advance multiple fields. PENSACOLA, Fla., July 8, 2022 /PRNewswire/ —… Read More >
A Letter from the CEO
Jun 15, 2021
Regenative Labs to-date produces the first and only Wharton’s jelly allograft to be recognized as a 361 HCT/P by any… Read More >
Regenative Labs: Medicare Approval for Wharton’s Jelly Reimbursement
Aug 05, 2020
PENSACOLA, FLA. (PRWEB) AUGUST 05, 2020 Regenative Labs has received approval from the Centers for Medicare & Medicaid Services (CMS)… Read More >